Moshkani Farahani M, Nasiri A, Salari M, Shamsedini A. The therapeutic effect of PCSK9 inhibitors on dyslipidemia: one-year follow up. Eur J Transl Myol [Internet]. 2024 Sep. 13 [cited 2024 Dec. 21];34(3). Available from: https://www.pagepressjournals.org/bam/article/view/12937